Liu, C., Ni, L., Li, X., Rao, H., Feng, W., Zhu, Y., . . . Li, L. (2023). SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL. Clinical and translational medicine, 13(11), e1468-n/a. https://doi.org/10.1002/ctm2.1468
Chicago Style (17th ed.) CitationLiu, Changwei, et al. "SETD2 Deficiency Promotes Renal Fibrosis Through the TGF‐β/Smad Signalling Pathway in the Absence of VHL." Clinical and Translational Medicine 13, no. 11 (2023): e1468-n/a. https://doi.org/10.1002/ctm2.1468.
MLA (9th ed.) CitationLiu, Changwei, et al. "SETD2 Deficiency Promotes Renal Fibrosis Through the TGF‐β/Smad Signalling Pathway in the Absence of VHL." Clinical and Translational Medicine, vol. 13, no. 11, 2023, pp. e1468-n/a, https://doi.org/10.1002/ctm2.1468.